attach research report excerpt
research report written
entir broker partner auerbach
grayson auerbach grayson
auerbach grayson distributing/provid
research report consider
maintain buy rate increas price target base
earn growth anticip matrixcar acquisit success
connect care strategi sleep busi directli transferr
respiratori divis own matrix set market share
gain non- invas ventil portabl oxygen potenti even nasal high flow
solut interplay cloud-connect medic devic cost-sav
saa solut attract out-of-hospit healthcar provid
sleep provid acquisit immedi accret ad non-
ep
acquir privat held matrixcar leader long-term post-acut care
softwar serv facil base care set home
care home health group saa platform includ solut senior live
set skill nurs life plan commun homecar fund
acquisit exist debt bid price impli ev/ebitda
point acquisit lay groundwork grow sale respiratori
support devic non- invas ventil aircurv portabl oxygen
concentr mobi potenti even connect nasal high flow solut
reimburs support out-of-hospit set still develop sure
similar challeng reimburs complianc bill resm
airview brightre softwar solv sleep provid home medic equip
provid hme watch new portfolio connect devic
take market share respiratori healthcar provid tend offer patient
medic devic connect saa solut eg matrix save
money see matrixcar replic achiev u-sleep
brightre acquisit core sleep busi
acquisit immedi accret add pro forma ebitda higher
interest expens mute ep impact ep higher
assum rapid de-lever buy-back temporarili suspend even post
deal net leverag ebitda leav plenti capac futur
buy matrixcar earn strategi point
maintain buy rate increas price target
base earn growth anticip matrixcar acquisit
success connect care strategi
sleep busi directli transferr respiratori divis
own matrixcar set market share gain non-
invas ventil portabl oxygen potenti even nasal high flow
solut interplay cloud-connect medic devic
cost-sav saa solut attract out-of-hospit
healthcar provid sleep provid acquisit
immedi accret ad non-gaap ep
acquir matrixcar own softwar solut
across patient care continuum acquir privat held
matrixcar leader long-term post-acut care softwar serv
facil base care set home care home health
group saa platform includ solut senior live set skill
nurs life plan commun homecar fund acquisit
exist debt bid price impli ev/ebitda
set next chapter connect care medic devic market
share gain time respiratori point acquisit
lay groundwork grow sale respiratori support devic non-
invas ventil aircurv portabl oxygen concentr mobi
out-of-hospit set still develop sure requir on-going
challeng reimburs complianc bill airview
brightre softwar solv sleep provid home medic equip
provid hme watch new portfolio connect devic
take market share respiratori healthcar provid tend
offer patient medic devic connect saa solut eg matrix
save money see matrixcar replic achiev
u-sleep brightre acquisit core sleep busi
model chang acquisit immedi accret add pro forma
ebitda higher interest expens mute ep impact
ep higher assum rapid de-lever buy-back temporarili
suspend even post deal net leverag ebitda leav
plenti capac futur
valuat new price target per cdi impli cash ep
ev/ebitda valuat premium rel peer
sustain basi connect care contribut high margin earn
growth increment medic devic market share multipl channel
risk catalyst
risk advers reimburs cut sleep apnoea fund product
launch competitor litig includ patent infring suit
develop indic outsid sleep apnoea
share issu
issu wilson advisori stockbrok limit abn australian financi servic licenc particip asx group
read conjunct disclosur disclaim report import disclosur regard compani subject report explan
recommend found end document
health equip suppli
profit loss
fund equiti
fund debt
fund cash
health equip suppli
agre pay healthcar softwar compani matrixcar bid
price impli ev/ebitda forecast transact fund
exist debt facil expect settl end matrixcar
expect record revenu ebitda respect resm
claim acquisit immedi accret gross margin ep non-gaap
basi done follow brightre acquisit temporarili suspend
share repurchas program note assess deal financi longer term
matrixcar acquisit complementari resm exist solut home medic
equip home health hospic deliv brightre healthcarefirst
chang oper assumpt core busi
matrixcar revenu lift group estim
mute ep impact increment earn off-set increas
interest expens major consider fund addit debt
ep increas
tabl chang forecast
health equip suppli
matrixcar solut provid softwar technolog across skill nurs senior live
life plan commun homecar organ across patient-car servic financi
oper market product compani softwar use facil
base care set home care home health hospic organ
solut help advanc care organ life plan commun home health
organ connect collabor long term post-acut care industri
consolid integr fee-for-valu model solut also purpose-built
health electron record compon increas qualiti organ
use analyt clinic decis support care coordin platform system allow
provid share data referr partner monitor care qualiti profit
matter
long term beneficiari consolid long term post-acut ltpa care
set matrixcar signific expans healthcar saa reach tap
expenditur us healthcar system physician/clin servic
homecar skill nurs facil despit improv medic servic
technolog patient still experi inconsist qualiti fragment care poorli align
payment matrixcar consolid resolv issu across continuum long
term care patient rang hospit hospic homecar creat effici
care centr physician payer ltpa sector consolid seek cost
effici matrixcar well establish market import tool facilit
chang grow market share yoy past three year
set next connect care raid out-of-hospit respiratori
matrixcar strong philosoph align achiev sleep
market connect care strategi saa solut help healthcar provid
optimis econom healthcar deliveri increasingli fee valu
reimburs environ usa see acquisit intern
 lay groundwork healthcar provid adopt connect medic
devic out-of-hospit set aircurv flow gener non-invas ventil
medic devic reimburs set develop alongsid outcom
evid nowaday respiratori care patient secur unbroken lifelin
medic devic reimburs move differ care set exampl
chronic obstruct pulmonari diseas copd patient often introduc medic
devic therapi acut set emerg hospit face circuit
frustrat process secur on-going reimburs devic home hospic
set copd patient often access reimburs via sleep apnoea rout given
high level comorbid copd obstruct sleep apnoea osa
patient access reimburs continu improv longer term longitudin trial
establish measur benefit home base respiratori assist
connect medic devic come portfolio
alreadi connect commonli use patient copd
neuromuscular diseas and/or hypoventil compani day septemb
manag confirm second iter mobi portabl oxygen concentr
would also connect devic final clearli evalu entri
nasal high flow categori current domin fisher paykel may develop and/or
acquir connect solut nasal high flow tradit acut sub-acut
therapi clear momentum push devic homecar particularli
copd patient struggl secret manag recent list vapotherm
could interest target high-flow
consid comfort well-toler patient
vapotherm disclos million patient treat compani precis system sold capit unit
sell product us via direct sale organ distributor countri outsid us revenu gross margin
compani lost larg attribut sg expenditur gross margin meaning lower compani
similar busi fph exampl
health equip suppli
increas price target per cdi previous per cdi chang
reflect addit matrixcar earn support longer term growth rate within
valuat per share impli ev/ebitda per stock
trade premium intern med-tech peer premium recognis market
leadership superior earn qualiti potenti growth option indic
sleep via connect care strategi
tabl dcf summari valuat
dcf forecast period growth risk debt us long run oper featur sleep apneapv fcff revenu ot gross sg net net debt net basic dilut stock tp us /share us common tp data nametickermkt medic devic peersfish paykel healthcar corpor dickinson demant hold hold norm ebitda margin
health equip suppli
resm inc develop manufactur sell posit air pressur pap devic treatment sleep disord breath recent
year compani diversifi pap offer market oral applianc ventil form respiratori support
maintain buy rate increas price target base earn growth anticip matrixcar acquisit
success connect care strategi sleep busi directli transferr respiratori divis own
matrixcar set market share gain non-invas ventil portabl oxygen potenti even nasal high flow solut
interplay cloud-connect medic devic cost-sav saa solut attract out-of-hospit healthcar provid
sleep provid acquisit immedi accret ad non-gaap ep
grow easier access diagnosi sleep disord
rel short product cycl refresh price point
new devic area
gross margin expos fx aud sgd vs usd
 sg typic net sale
product mix higher-end apap ventil bilevel mask
higher gross margin
competit intensifi low-end cpap market
net debt averag ntm impli net leverag
restor sustain industri us devic volum flow
increment margin benefit mix shift apap
risk view
increas competit price point
slower-than-expect market growth particularli challeng
price reimburs challeng usa elsewher
relat poor complianc cpap
health equip suppli
disclaim disclosur
